
Oncology NEWS International
- Oncology NEWS International Vol 12 No 2
- Volume 12
- Issue 2
Ethnic Differences in Breast Cancer Treatments, Outcomes
SEATTLE-A Fred Hutchinson Cancer Research Center study documents important disparities in breast cancer diagnosis, treatment, and survival among American women of various ethnicities. The findings by Christopher Li, MD, PhD, and his colleagues (Arch Intern Med 163:49-56, 2003) are based on data from 11 tumor registries participating in the Surveillance, Epidemiology, and End Results (SEER) program, including 124,934 women diagnosed with first primary invasive breast cancer from 1992 to 1998.
SEATTLEA Fred Hutchinson Cancer Research Center study documents important disparities in breast cancer diagnosis, treatment, and survival among American women of various ethnicities. The findings by Christopher Li, MD, PhD, and his colleagues (Arch Intern Med 163:49-56, 2003) are based on data from 11 tumor registries participating in the Surveillance, Epidemiology, and End Results (SEER) program, including 124,934 women diagnosed with first primary invasive breast cancer from 1992 to 1998.
The analysis showed that blacks, American Indians, Hawaiians, Indians and Pakistanis, Mexicans, South and Central Americans, and Puerto Ricans had a 1.4- to 3.6-fold greater risk of presenting with stage IV breast cancer, relative to non-Hispanic whites. Blacks, Mexicans, and Puerto Ricans were 20% to 50% more likely to receive a first course of surgical and radiation therapy that did not meet the 2000 National Comprehensive Cancer Network (NCCN) guidelines. Blacks, American Indians, Hawaiians, Vietnamese, Mexicans, South and Central Americans, and Puerto Ricans had a 20% to 200% greater mortality risk after a breast cancer diagnosis.
Articles in this issue
almost 23 years ago
Some Activity for Gefitinib in Heavily Pretreated Breast Canceralmost 23 years ago
Brachytherapy Results Similar for Blacks, Whitesalmost 23 years ago
Dose-Dense Chemo Ups Survival in Node+ Breast Canceralmost 23 years ago
MR Spectroscopy IDs Breast Cancers, Node Involvementalmost 23 years ago
ODAC Wants More Data on Expanded Casodex Indicationalmost 23 years ago
SuperGen Submits First NDA Module for Pancreatic Cancer Drugalmost 23 years ago
Two Added to ONI’s Oncology Nursing Editorial Advisory Boardalmost 23 years ago
Bortezomib Active in Relapsed/Refractory Myelomaalmost 23 years ago
Telomerase Potential Cancer BiomarkerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.




















































































